SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-027513
Filing Date
2019-05-07
Accepted
2019-05-07 16:31:45
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7174_110q.htm 10-Q 700631
2 EX-10.1 a19-7174_1ex10d1.htm EX-10.1 59712
3 EX-31.1 a19-7174_1ex31d1.htm EX-31.1 11993
4 EX-31.2 a19-7174_1ex31d2.htm EX-31.2 11982
5 EX-32.1 a19-7174_1ex32d1.htm EX-32.1 7725
  Complete submission text file 0001104659-19-027513.txt   4904013

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cldx-20190331.xml EX-101.INS 1191586
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20190331.xsd EX-101.SCH 36026
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20190331_cal.xml EX-101.CAL 53315
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20190331_lab.xml EX-101.LAB 383342
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20190331_pre.xml EX-101.PRE 288576
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20190331_def.xml EX-101.DEF 147707
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 19803574
SIC: 2835 In Vitro & In Vivo Diagnostic Substances